EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor 2.1

Ensembl ID : ENSELUG00000007082
Gene Symbol: F2R2.1
1 Cross references
265 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSELUG00000002446
Gene Symbol: F3
3 Cross references
199 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSELUG00000028406
Gene Symbol: F7L
1 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSELUG00000024556
Gene Symbol: F10
1 Cross references
246 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSELUG00000015950
Gene Symbol: LOC105027740
2 Cross references
214 Possible Orthologues:

Coiled-Coil Domain-Containing Protein 6

Ensembl ID : ENSELUG00000017537
Gene Symbol: LOC105026300
4 Cross references
151 Possible Orthologues:

Coiled-Coil Domain-Containing Protein 6

Ensembl ID : ENSELUG00000005517
Gene Symbol: LOC105010545
3 Cross references
208 Possible Orthologues:

Collagenase 3

Ensembl ID : ENSELUG00000026235
Gene Symbol: LOC105005971
2 Cross references
318 Possible Orthologues:

Collagenase 3

Ensembl ID : ENSELUG00000006422
Gene Symbol: LOC105005972
2 Cross references
318 Possible Orthologues:

Collagenase 3

Ensembl ID : ENSELUG00000032642
Gene Symbol: LOC105005971
2 Cross references
318 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSELUG00000024581
Gene Symbol: CSF1R
1 Cross references
201 Possible Orthologues:

Complement C5

Ensembl ID : ENSELUG00000009867
Gene Symbol: C5
1 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).